“We expect to open our first Phase 2 clinical trial site in New Zealand this quarter and then expand the trial globally in the UK, other European countries, Australia and the United States.
I believe it is the third time they officially mentioned the expected commencement in NZ would be in this quarter. It is already delayed for half a year, I hope this will definitely happen in Q2 (two months left) and not being moved to 2H!
Ann: UK Regulatory Authorisation to Proceed with Phase 2 Trial, page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $10.36K | 3.454M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 105565118 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 4171982 | 3 |
View Market Depth
| Last trade - 10.43am 17/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |